Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05688514

TVMR With the Innovalve System Trial - First In Human Israel

Conditions: Mitral Valve Regurgitation (Degenerative or Functional)

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 10

Sponsor: Innovalve Bio Medical Ltd.

Location: Israel

Summary

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Eligibility Criteria

Inclusion Criteria:Clinically significant, symptomatic mitral regurgitationHigh risk for open-heart surgeryMeets anatomical criteriaExclusion Criteria:Unsuitable anatomyPatient is inoperableEF<25%

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05688514). StuddyBuddy aggregates publicly available trial information.